189 related articles for article (PubMed ID: 37809067)
21. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
[TBL] [Abstract][Full Text] [Related]
22. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
23. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models.
Yati S; Silathapanasakul A; Thakaeng C; Chanasakulniyom M; Songtawee N; Porntadavity S; Pothacharoen P; Pruksakorn D; Kongtawelert P; Yenchitsomanus PT; Chanmee T
Cells; 2022 Mar; 11(6):. PubMed ID: 35326493
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.
Siewe B; Pham JT; Cohen M; Hessol NA; Levine A; Martinez-Maza O; Landay A
AIDS; 2015 Aug; 29(13):1659-64. PubMed ID: 26372276
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.
Peckham-Gregory EC; Thapa DR; Martinson J; Duggal P; Penugonda S; Bream JH; Chang PY; Dandekar S; Chang SC; Detels R; Martínez-Maza O; Zhang ZF; Hussain SK
Cancer Epidemiol; 2016 Dec; 45():47-57. PubMed ID: 27701053
[TBL] [Abstract][Full Text] [Related]
27. Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Signorelli D; Ghidotti P; Proto C; Brambilla M; De Toma A; Ferrara R; Galli G; Ganzinelli M; Lo Russo G; Prelaj A; Occhipinti M; Viscardi G; Capizzuto V; Pontis F; Petraroia I; Ferretti AM; Colombo MP; Torri V; Sozzi G; Garassino MC; Jachetti E; Fortunato O
Front Immunol; 2022; 13():987639. PubMed ID: 36203609
[TBL] [Abstract][Full Text] [Related]
28. Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.
Scilla KA; Zandberg DP; Bentzen SM; Mainor C; Heath J; Ioffe OB; Cellini AL; Edelman MJ; Riedel DJ; Feliciano JL
Lung Cancer; 2018 Sep; 123():87-90. PubMed ID: 30089601
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma.
Liu X; Zhang Y; Han Y; Lu W; Yang J; Tian J; Sun P; Yu T; Hu Y; Zhang H; Huang P; Liu P
Mol Oncol; 2020 May; 14(5):1028-1044. PubMed ID: 32157792
[TBL] [Abstract][Full Text] [Related]
30. Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.
Song M; Bassig BA; Bender N; Goedert JJ; Winkler CA; Brenner N; Waterboer T; Rabkin CS
AIDS Res Hum Retroviruses; 2020 May; 36(5):381-388. PubMed ID: 31789046
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
Yoh KE; Lowe CJ; Mahajan S; Suttmann R; Nguy T; Reichelt M; Yang J; Melendez R; Li Y; Molinero L; Ruppel J; Xu W; Plaks V
J Immunol Methods; 2021 Mar; 490():112936. PubMed ID: 33242493
[TBL] [Abstract][Full Text] [Related]
32. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
[TBL] [Abstract][Full Text] [Related]
33. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.
Vendrame E; Martínez-Maza O
J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858
[TBL] [Abstract][Full Text] [Related]
34. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
35. Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without non-Hodgkin lymphoma.
Zhuang K; Zhang Y; Mo P; Deng L; Jiang Y; Yu L; Mei F; Huang S; Chen X; Yan Y; Tang H; Li X; Xiong Y; Wu S; Ke H; Gui X; Lan K
J Med Virol; 2022 Aug; 94(8):3876-3889. PubMed ID: 35415847
[TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies.
Izquierdo E; Vorholt D; Blakemore S; Sackey B; Nolte JL; Barbarino V; Schmitz J; Nickel N; Bachurski D; Lobastova L; Nikolic M; Michalik M; Brinker R; Merkel O; Franitza M; Georgomanolis T; Neuhaus R; Koch M; Nasada N; Knittel G; Chapuy B; Ludwig N; Meese E; Frenzel L; Reinhardt HC; Peifer M; Rebollido-Rios R; Bruns H; Krüger M; Hallek M; Pallasch CP
Blood; 2022 Jun; 139(25):3617-3629. PubMed ID: 35344582
[TBL] [Abstract][Full Text] [Related]
37. Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC.
Shukuya T; Ghai V; Amann JM; Okimoto T; Shilo K; Kim TK; Wang K; Carbone DP
J Thorac Oncol; 2020 Nov; 15(11):1773-1781. PubMed ID: 32565389
[TBL] [Abstract][Full Text] [Related]
38. Localized Imaging of Programmed Death-Ligand 1 on Individual Tumor-Derived Extracellular Vesicles for Prediction of Immunotherapy Response.
Zhang J; Guan M; Lv M; Liu Y; Zhang H; Zhang Z; Zhang K
ACS Nano; 2023 Oct; 17(20):20120-20134. PubMed ID: 37819165
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]